These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25467593)

  • 21. Vaccine tests to begin in Ebola countries this year.
    Gulland A
    BMJ; 2014 Oct; 349():g6466. PubMed ID: 25344380
    [No Abstract]   [Full Text] [Related]  

  • 22. Ebola vaccine to be tested on 30,000 volunteers.
    Gulland A
    BMJ; 2015 Jan; 350():h448. PubMed ID: 25616423
    [No Abstract]   [Full Text] [Related]  

  • 23. Ebola vaccine trial in west Africa faces criticism.
    Shuchman M
    Lancet; 2015 May; 385(9981):1933-4. PubMed ID: 25979835
    [No Abstract]   [Full Text] [Related]  

  • 24. Federal funding in support of Ebola medical countermeasures R&D.
    Boddie C
    Health Secur; 2015; 13(1):3-8. PubMed ID: 25812423
    [No Abstract]   [Full Text] [Related]  

  • 25. Share the risks of Ebola vaccine development.
    Berkley S
    Nature; 2015 Mar; 519(7543):263. PubMed ID: 25788059
    [No Abstract]   [Full Text] [Related]  

  • 26. Early trials of Ebola vaccine show immune response.
    Mayor S
    BMJ; 2015 Apr; 350():h1844. PubMed ID: 25855620
    [No Abstract]   [Full Text] [Related]  

  • 27. Ebola vaccine trials back on track.
    Mohammadi D
    Lancet; 2015 Jan; 385(9964):214-5. PubMed ID: 25601786
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical trials of Ebola vaccine must continue despite fall in number of cases.
    Gulland A
    BMJ; 2015 Feb; 350():h944. PubMed ID: 25691506
    [No Abstract]   [Full Text] [Related]  

  • 29. The importance of patent sharing in neglected disease drug discovery.
    Edlin C
    Future Med Chem; 2011 Sep; 3(11):1331-4. PubMed ID: 21879838
    [No Abstract]   [Full Text] [Related]  

  • 30. The Ebola Epidemic. High hopes for Guinean vaccine trial.
    Enserink M
    Science; 2015 Jan; 347(6219):219-20. PubMed ID: 25593164
    [No Abstract]   [Full Text] [Related]  

  • 31. Experimental vaccine may have saved Hamburg scientist from Ebola fever.
    Tuffs A
    BMJ; 2009 Mar; 338():b1223. PubMed ID: 19307268
    [No Abstract]   [Full Text] [Related]  

  • 32. Is the world ready for an Ebola vaccine?
    Lee BY; Moss WJ; Privor-Dumm L; Constenla DO; Knoll MD; O'Brien KL
    Lancet; 2015 Jan; 385(9964):203-4. PubMed ID: 25706696
    [No Abstract]   [Full Text] [Related]  

  • 33. INFECTIOUS DISEASES. Unusual Ebola vaccine study pays off in Guinea.
    Enserink M
    Science; 2015 Aug; 349(6248):569-70. PubMed ID: 26250660
    [No Abstract]   [Full Text] [Related]  

  • 34. Ebola as a case study for the patent landscape of medical countermeasures for emerging infectious diseases.
    Mohajel N; Arashkia A
    Nat Biotechnol; 2021 Jul; 39(7):799-807. PubMed ID: 34257454
    [No Abstract]   [Full Text] [Related]  

  • 35. Proposed changes to patent code loom over biotech industry.
    Coombs A
    Nat Biotechnol; 2007 Dec; 25(12):1333-4. PubMed ID: 18066010
    [No Abstract]   [Full Text] [Related]  

  • 36. Ebola vaccine trial results are "extremely promising," says WHO.
    Kmietowicz Z
    BMJ; 2015 Jul; 351():h4192. PubMed ID: 26232397
    [No Abstract]   [Full Text] [Related]  

  • 37. An Ebola vaccine: first results and promising opportunities.
    Lancet; 2015 Aug; 386(9996):830. PubMed ID: 26248675
    [No Abstract]   [Full Text] [Related]  

  • 38. Positive results spur race for Ebola vaccine.
    Callaway E
    Nature; 2014 Dec; 516(7529):15-6. PubMed ID: 25471858
    [No Abstract]   [Full Text] [Related]  

  • 39. Ebola vaccine is safe and immunogenic, results show.
    Gulland A
    BMJ; 2015 Jan; 350():h524. PubMed ID: 25633684
    [No Abstract]   [Full Text] [Related]  

  • 40. Viral complacency.
    Nature; 2016 Apr; 532(7597):5. PubMed ID: 27078526
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.